Pre-production brief
| Field | Definition |
|---|---|
| Reader | Founder preparing U.S. FDA market-entry planning. |
| Trigger | The team is about to ask about pathway, predicate, fee, or consultant strategy. |
| Blocked decision | Public source clues are scattered and do not yet form a review packet. |
| Useful output | A U.S. FDA market-entry research packet with source ledger and open questions. |
What belongs in the first packet
- Intended-use and device-description draft.
- Candidate product-code and classification clues with source links.
- Similar-device or 510(k) records with same/different notes.
- Safety-history scan using public FDA sources where relevant.
- User-fee and eSTAR context for planning questions.
- Open questions for RA/QA, consultant, counsel, or FDA-facing review.
What the packet cannot decide
The packet can make public evidence visible, but it cannot decide classification, pathway, predicate suitability, substantial equivalence, evidence sufficiency, or submission strategy.
Those decisions depend on product facts, intended use, technology, risk, evidence, and professional judgment that public source collection alone cannot supply.
What TrueMedDevice can prepare
TrueMedDevice can prepare a U.S. FDA market-entry research packet with public-source links, candidate clues, safety-history context, fee references, eSTAR context, and consultant questions.
Source ledger
What it can tell you
FDA's public device database entry points for product research.
What it cannot decide
Which public records are sufficient for a specific device's regulatory strategy.
What it can tell you
Public classification and product-code entries that may support candidate review questions.
What it cannot decide
The final product code, class, or pathway for a specific device.
What it can tell you
FDA's general 510(k) pathway context and submission overview.
What it cannot decide
Whether a specific device is eligible for 510(k) or substantially equivalent.
What it can tell you
FDA's public user-fee context for submission planning.
What it cannot decide
The final cost, submission type, fee eligibility, or budget for a specific company.
What it can tell you
FDA's structured electronic submission template context.
What it cannot decide
Whether a specific device's evidence is complete or acceptable.
Frequently asked questions
Does this guide tell me which FDA pathway applies?
No. It prepares the public-source packet that qualified reviewers can use when they evaluate pathway questions.
What should I bring to a consultant?
Bring intended-use language, product-code clues, similar-device records, safety-history source checks, fee context, and a written list of open questions.
Why not start with the 510(k) database only?
A 510(k) search can be useful, but market-entry planning also needs intended-use context, product-code clues, safety-history context, fee planning, and clear source limits.
Need the U.S. market-entry research packet before the consultant call?
TrueMedDevice can organize the intended-use note, source ledger, candidate clues, safety-history scan, fee context, and open questions.
Reader feedback
Useful pages should feed the next topic choices. Leave a signal or a short comment.